Background Multiple sclerosis (MS) is a chronic and progressive neurological autoimmune
disease that affects the central nervous system. There are two types of drugs used to treat …

Introduction The introduction of disease-modifying therapies (DMTs) for relapsing multiple
sclerosis (RMS) over the last two decades has prompted the economic assessments of …

Introduction Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths
of the nerve cells in the brain and spinal cord, which are responsible for communication, are …

The very fact that multiple sclerosis (MS) is incurable and necessitates life-long care makes
it one of the most burdensome illnesses. The aim of this study was to compare the cost …

Objectives Multiple sclerosis (MS) comprises a chronic, neurodegenerative, and
inflammatory illness of the central nervous system that affects 2.8 million people worldwide …

Background Patients with highly active relapsing-remitting multiple sclerosis inadequately
responding to first-line therapies (interferon-based therapies, glatiramer acetate, dimethyl …

Background: Breast cancer is one of the most prevalent malignancies in women worldwide,
and the rate of breast cancer is increasing among Iranian women. The purpose of this study …

Introduction: Despite the increasing role of patients in the US healthcare system, patients
have yet been engaged in the value assessment of their treatments, including disease …

Background The limited health care resources cannot meet all the demands of the society.
Thus, decision makers have to choose feasible interventions and reject the others. We …

Multiple Sclerosis (MS) is the most prevalent chronic inflammatory disease of the central
nervous system, characterized by demyelination, axonal damage and progressive disability …